PAHC — PHIBRO ANIMAL HEALTH CORPORATION (Healthcare >> Drug Manufacturers - Specialty & Generic)
PAHC FAQ
P/E của cổ phiếu PAHC là bao nhiêu?
PHIBRO ANIMAL HEALTH CORPORATION (PAHC) hiện giao dịch ở mức P/E 15.53 lần.
ROE của cổ phiếu PAHC là bao nhiêu?
PHIBRO ANIMAL HEALTH CORPORATION có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 26.32%.
Tỷ suất cổ tức của PAHC là bao nhiêu?
PHIBRO ANIMAL HEALTH CORPORATION có tỷ suất cổ tức 1.30%.
Điểm chất lượng (Quality Score) của PAHC là bao nhiêu?
AI của chúng tôi đánh giá chất lượng tài chính tổng thể của PAHC ở mức 77/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.
Bây giờ có nên mua cổ phiếu PAHC không?
Điểm AI Timing của PAHC là 51/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.
Cổ phiếu PAHC thuộc ngành nào?
PHIBRO ANIMAL HEALTH CORPORATION được xếp vào ngành Healthcare >> Drug Manufacturers - Specialty & Generic trên sàn NASDAQ
PAHC AI Analysis Summary
Our AI summary for PAHC: PHIBRO ANIMAL HEALTH CORPORATION (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 15.53, ROE of 26.32%, a dividend yield of 1.30%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 36.33
Price
-0.12
(-0.33%)
Day Change
|
|
|---|
PAHC Chất lượng tổng thể của cố phiếu Tốt ( Chất lượng = 77) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
52% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
1515
|
| Magic Formula Rank by ROE |
1515
|
| Magic Formula Rank by ROIC |
801
|
| Price | 36.33 |
| PBV / Sector |
4.09 / 3.22
|
| Earning Per Share | 2.34 |
| PE / Sector |
15.53 / 29.79
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
8.68 M
|
| Average 1W Daily Value |
8.51 M
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
62% |
| Lợi tức cho nhà đầu tư |
|
12% |
| Chi tiết đăng ký |
| Analyze Date | 2026-08-01 08:00:18 |
| Symbol | PAHC |
| Name | PHIBRO ANIMAL HEALTH CORPORATION |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 21.07 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,478.58 / 10,754.62 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
Phone: 201 329 7300
Website: https://www.pahc.com
Employees: 2,475
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google